AstraZeneca pumps US$ 200 million to acquire rights into Ionis’ rare disease drug

by | Dec 10, 2021 | , , | 0

UNITED KINGDOM – AstraZeneca has announced that it would pay Ionis Pharmaceuticals, the market...

Read More